Laura Maria Calvi

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jonathan W Friedberg · 1 shared grant, 2026 · strength 0.86
   • Grant Genetics, Epigenetics and Metabolism Research Program P30CA272302↗
2. Paula M. Vertino · 1 shared grant, 2026 · strength 0.86
   • Grant Genetics, Epigenetics and Metabolism Research Program P30CA272302↗
3. Darren R. Carpizo · 1 shared grant, 2026 · strength 0.86
   • Grant Genetics, Epigenetics and Metabolism Research Program P30CA272302↗
4. Hani A Awad · 1 shared grant, 2023 · strength 0.61
   • Grant Training in Musculoskeletal Science: Comprehensive Training in Pain Studies T32AR076950↗
5. Danielle S. Benoit · 1 shared grant, 2023 · strength 0.61
   • Grant Training in Musculoskeletal Science: Comprehensive Training in Pain Studies T32AR076950↗
6. David C. Linehan · 3 shared papers, 2024–2026 · strength 0.57
   • Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
7. Tara G Vrooman · 3 shared papers, 2024–2026 · strength 0.57
   • Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
8. Angela L. Hughson · 3 shared papers, 2024–2026 · strength 0.57
   • Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
9. Scott A. Gerber · 3 shared papers, 2024–2026 · strength 0.57
   • Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
10. Haoming Qiu · 2 shared papers, 2024–2026 · strength 0.38
    • Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
    • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
11. Bradley N. Mills · 2 shared papers, 2024–2025 · strength 0.35
    • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
    • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
12. Jian Ye · 1 shared paper, 2025 · strength 0.19
    • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
13. Joseph D. Murphy · 1 shared paper, 2024 · strength 0.15
    • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.